Race Oncology Ltd (ASX:RAC)
Share Pricing & News Healthcare

AUD 2.3

0.09 (4.072%)
(As on 2022-12-01 20:57:05 AEDT)
Previous Close Open Close*
2.21 2.23 2.3
Market Cap Dividend Yield (Annualized)
AUD 370.744M 0.00%

Day Range
2.22L 2.3 H
52 WEEK HIGH LOW
1.45L 3.78 H

Chart Price & Information

Last Trade 2.3
Change% 4.0724
52 W H/L 3.780/1.450
EBITDA -11.683M
NPAT After Abnormal Items -11.202M
Equity 36.107M
ROE% -31.02%
Total Liabilities 1.417M
Total Revenue 707,807
Cash and Cash Equivalents 33.541M

Stock Information

Share price 2.3
Market Cap 370.744M
Price/Gross Cash Flow -40.94
Dividend Yield Excluding Special 0.00%
Ending Shares 159.52M
52-Week Range 3.780-1.450
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.21
P/E ratio 0.000
Sector P/E --
EPS -7.28
EV/EBITDA --
Net Profit Margin (%) --
Gross Cash Flows Per Share -0.05
Net Gearing -92.89%
Sales Per Share 0.00
Book Value Per Share 0.23

Similar Companies

Related Articles

About Company

The company was listed in 2016, the headquarter of the company is situated in Collins Street, Docklands, Australia. The company is into development of Bisantrene, cancer drug under the health care sector. The company was formerly known as Coronado Resources Limited.

Corporate Information


Level 36, Gateway, 1 Macquarie Place, SYDNEY, NSW, AUSTRALIA, 2000

Phone:+61 3 9098 8750

Website:http://www.raceoncology.com

Dividends

Ex-Date Net Dividend Frank Flag Period End Date Type Payable

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2023-10-23 2023
Report (Annual) 2023-08-25 2023
Report (Prelim) 2023-08-25 2023
Report (Interim) 2023-02-24 2023